Liraglutide preserves CD34(+) stem cells from dysfunction Induced by high glucose exposure

BACKGROUND: Glucagon like peptide-1 receptor agonists (GLP-1RAs) have shown to reduce mortality and cardiovascular events in patients with type 2 diabetes mellitus (T2DM). Since the impairment in number and function of vasculotrophic circulating CD34(+) hematopoietic stem progenitor cells (HSPCs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sforza, Annalisa, Vigorelli, Vera, Rurali, Erica, Perrucci, Gianluca Lorenzo, Gambini, Elisa, Arici, Martina, Metallo, Alessia, Rinaldi, Raffaella, Fiorina, Paolo, Barbuti, Andrea, Raucci, Angela, Sacco, Elena, Rocchetti, Marcella, Pompilio, Giulio, Genovese, Stefano, Vinci, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994898/
https://www.ncbi.nlm.nih.gov/pubmed/35397526
http://dx.doi.org/10.1186/s12933-022-01486-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994898/
https://www.ncbi.nlm.nih.gov/pubmed/35397526
http://dx.doi.org/10.1186/s12933-022-01486-9

Ejemplares similares